medigraphic.com

2006, Number S2

<< Back Next >>

Arch Cardiol Mex 2006; 76 (S2)

Clinical stratification of cardiogenic shock

Martínez SCR, Martínez-Reding G JO, Lupi HE

Language: Spanish
References: 21
Page: 261-268
PDF size: 120.19 Kb.


ABSTRACT

Cardiogenic shock (CHC) associated to acute myocardial infarct has high mortality and their manifestations are heterogenous. In our institution historical mortality, was 98%, but with different methods of reperfusion, its reduced to 53%. In other hand, with opportune clinical stratification is useful to improve the treatment strategy. This stratification on basis in clinical signs: age, infarction location, cardiac frequency and systemic arterial pressure, and hemodynamical valuation with the use of right catheterism with quantification miocardial work parameters like “Cardiac power” that is the product of flow and arterial pressure and that is of utility to know the “Miocardial reserve”. In our experience after reperfusion procedure patients with CHC and cardiac power less than 1.0 had highly mortality.


REFERENCES

  1. ALPERT JS, BECKER RC: Cardiogenic Shock: Elements of Etiology. Diagnosis, and therapy clinic. Cardiol 1993; 16: 182-190.

  2. HURTADO BA, SANTOME JA, FERNÁNDEZ RG, CÁRDENAS LM: Infarto del miocardio con choque cardiogénico. Arch Ins Nac Cardiol Mex 1984; 54: 121-129.

  3. O´NELL W: Angioplasty therapy of cardiogenic shock. Cardiology Clinics 1995; 13(3): 391-406.

  4. BATES E, TOPOL E: Limitation of trombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991; 18: 1077-1084.

  5. HOCHMAN J: Cardiogenic shock: Can we save the patient? ACC Educational Highlights 1996; 12: 1-5.

  6. HOCHMAN J, BOLAND J, SLEEPER LA, PORWAY M, ET AL: Current Spectrum of cardiogenic shock and effect of early revascularization on mortality shock registry investigators. Circulation 1995; 91: 873-881.

  7. HOCHMAN J, SLEEPER LA, WEBB JG, ET AL: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-634.

  8. LEE L, BATES ER: Percutaneous transluminal Coronary angioplasty improve survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988; 78: 1345-1351.

  9. MARTÍNEZ-SÁNCHEZ C, CHUQUIURE VE, FLORES R, GARCÍA LÓPEZ S, ET AL: Choque cardiogénico. Las variables de mortalidad. Gac Med Mex 2005; 141(5): 395-400.

  10. ELLIOTT M ANTMAN, DANIEL T ANBE, PAUL WAYNE ARMSTRONG: ACC/AHA Guidelines for the managements of patients with ST-Elevation myocardial infarction-Executive summary a report of the American College of Cardiology/American heart Association task force on practice Guidelines (writing Committee to revise the 1999 Guidelines for the management of patients with acute myocardial infarction. Circulation 2004: 110: 588-636.

  11. NOHRIA A, MIELNICZUK L, STEVENSON L: Evaluation and monitoring of patients with acute heart failure syndrome. Am J Cardiol 2005; 96(1): 32G-40G.

  12. DELLINGER R, CARLET J, MASUR H, ET AL: Surviving sepsis campaign guidelines for management of severe sepsis and septil shock. Crit Care Med 2004; 32(3): 858-873.

  13. HOLLENBERG S, KAVINSKY C, PARRILLO J: Cardiogenic shock. Ann Inter Med 1999; 131: 47-59.

  14. NIEMIEN M, BOHN M, COWIE M, ET AL: Executive summary of the guidelines on the diagnosis and treatment of acute Herat failure. The task force on acute failure of the European Society of Cardiology. Task force members. ESC 2005; 26(4): 384-416.

  15. MARTÍNEZ-SÁNCHEZ C, ROSAS M: Fisiología básica de la circulación en anestesia cardiovascular. 2ª Edición. Ed. Pastor Luna. McGraw-Hill Interamericana. 1997: 21-23.

  16. COTTER Q, WILLIAMS S, VERED Z, TAN LB: Role of the cardiac power in heart failure. Curr Opin Cardiol 2003; 18: 215-222.

  17. CUÉLLAR B. Poder cardíaco como factor pronóstico de sobrevida en pacientes con infarto agudo del miocardio complicado con choque cardiogénico. Tesis recepcional de la Especialidad de Cardiología Clínica. Instituto Nacional de Cardiología “Ignacio Chávez”.

  18. TAN LB, LITTLER WA. Measurement of cardiac reserve in cardiogenic shock. Implication of prognosis and management. Br Heart J 1990; 64: 121-128.

  19. TAN LB. Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Cardiovasc Research 1987; 21: 615-622.

  20. CHUQUIURE VE, VIEYRA G, JUÁREZ U, ET AL: Valor e importancia en la modificación de la reserva miocárdica en los enfermos con infarto del miocardio de localización inferior y extensión al ventrículo derecho con grave compromiso hemodinámico. XX Congreso Interamericano y XXIV Congreso Nacional de Cardiología. Cancún 2006.

  21. LUPI HE, GONZÁLEZ H, CHUQUIURE VE, CUÉLLAR B, MARTÍNEZ-SÁNCHEZ C. Poder cardíaco como parámetro para conocer la capacidad cardíaca como bomba y determinar el pronóstico a corto plazo en el choque cardiogénico por infarto agudo del miocardio. Arch Cardiol Mex 2006. En prensa.




2020     |     www.medigraphic.com